The Women's Tennis Association (WTA) is introducing a one-time mandatory genetic test for all players, effective Tuesday, as a condition for competing at the 2028 Los Angeles Olympics.
The WTA this week updated its eligibility policy for women's competition and introduced gender verification "based on biological sex" to "preserve the integrity of professional women's tennis and ensure a level playing field for all players."
The organization has complied with eligibility rules adopted by the International Olympic Committee (IOC) in March, in line with US President Donald Trump's executive order on sports ahead of the 2028 Olympic Games in Los Angeles.
The tennis players will be tested for the SRY gene. The test for the SRY gene, which is part of the Y chromosome and causes the development of male characteristics, can be done with a cheek swab or a blood test. The test is a reliable indicator for determining biological sex.
Players will be tested only once, and only a negative result confirming that the SRY gene is not present will allow them to compete on the Tour.
If the test is positive, the players will have to undergo additional medical evaluation before they are allowed to perform.
Mandatory gender testing, already implemented by international sports bodies in athletics, skiing and boxing, has been criticized by human rights experts and activist organizations.
See more:
Download the app and follow the news
FOLLOW US ON
